Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > ETalien another poster with no direction

<< Previous

Bullboard Posts

Next >>

Post by PowerofNowon Mar 10, 2021 8:49pm

153 Views

Post# 32769314

ETalien another poster with no direction

Hey do yourself a favor people if your gonna buy a stock and talk about it here don't start switching up your views going from a pumper one week to a basher with no hope the next. Account IGNORED.

ETalien wrote: After months of waiting to get the stock unhalted we have this to look forward to, a PP of 5 cents?
N.O. implementation in the portfolio has done nothing to the PPS! All this news may it be positive has also had zero affect on the market cap! I'm definitely not happy where we are sitting!

My daily RANT!

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China